LDLR and familial hypercholesterolemia: This lowering of intracellular cholesterol normally stimulates the synthesis of the LDL receptors (81) but with homozygous familial hypercholesterolemia, a condition caused by mutations in the low-density lipoprotein receptor (LDLR), patients may respond poorly or not at all to statin therapy (82).